Each year, Challenges magazine publishes its selection of the 100 startups where to invest - 2023 , a reference list widely followed by investors, industry leaders, and innovation stakeholders. Built with the support of an expert jury and external contributors from the startup and investment ecosystem, this ranking highlights young companies combining strong technological foundations, market relevance, and long-term growth potential.

In 2023, Beams was included in this selection, recognizing the efforts carried out to transform advanced scientific research into a robust medical technology project. This acknowledgment reflects years of work at the crossroads of physics, nuclear medicine, engineering, and clinical needs, as well as a clear ambition to address critical challenges in cancer surgery.

Beyond visibility, being featured in the Challenges ranking reinforces Beams’ credibility within the deeptech ecosystem. It helps accelerate discussions with partners, investors, and institutions, while confirming the strategic direction taken by the team.

This distinction marks an important milestone in Beams’ development and supports its continued mission: translating cutting-edge science into meaningful clinical impact.

‍